Enzon Pharmaceuticals, Inc. EZ1.F Stock
0.12 EUR
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
9.07M EUR
LOW - HIGH [24H]
0.12
-
0.12 EUR
VOLUME [24H]
30 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR
Enzon Pharmaceuticals, Inc. Price Chart
Enzon Pharmaceuticals, Inc. EZ1.F Financial and Trading Overview
| Enzon Pharmaceuticals, Inc. stock price | 0.12 EUR |
| Previous Close | 0.08 EUR |
| Open | 0.13 EUR |
| Bid | 0.13 EUR x 500000 |
| Ask | 0.18 EUR x 406100 |
| Day's Range | 0.13 - 0.13 EUR |
| 52 Week Range | 0.06 - 0.39 EUR |
| Volume | 50 EUR |
| Avg. Volume | 19 EUR |
| Market Cap | 17.18M EUR |
| Beta (5Y Monthly) | 0.198591 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | September 30, 2019 |
| 1y Target Est | N/A |
EZ1.F Valuation Measures
| Enterprise Value | 2.48M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 660.705 |
| Price/Book (mrq) | 3.1707315 |
| Enterprise Value/Revenue | 95.402 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Enzon Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | 0.198591 |
| 52-Week Change | -65.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.39 EUR |
| 52 Week Low | 0.06 EUR |
| 50-Day Moving Average | 0.13 EUR |
| 200-Day Moving Average | 0.19 EUR |
EZ1.F Share Statistics
| Avg. Volume (3 month) | 19 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 74.21M |
| Float | 30.21M |
| Short Ratio | N/A |
| % Held by Insiders | 10.70% |
| % Held by Institutions | 48.58% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 1161.53% |
| Operating Margin (ttm) | -3923.076% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -1.35% |
| Return on Equity (ttm) | 0.64% |
Income Statement
| Revenue (ttm) | 26K EUR |
| Revenue Per Share (ttm) | 0 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 26K EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -973000 EUR |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 45.88M EUR |
| Total Cash Per Share (mrq) | 0.62 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 113.375 |
| Book Value Per Share (mrq) | 0.041 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -277000 EUR |
| Levered Free Cash Flow (ttm) | -978500 EUR |
Profile of Enzon Pharmaceuticals, Inc.
| Country | Germany |
| State | NJ |
| City | Cranford |
| Address | 20 Commerce Drive |
| ZIP | 07016 |
| Phone | 732 980 4500 |
| Website | https://www.enzon.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Q&A For Enzon Pharmaceuticals, Inc. Stock
What is a current EZ1.F stock price?
Enzon Pharmaceuticals, Inc. EZ1.F stock price today per share is 0.12 EUR.
How to purchase Enzon Pharmaceuticals, Inc. stock?
You can buy EZ1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Enzon Pharmaceuticals, Inc.?
The stock symbol or ticker of Enzon Pharmaceuticals, Inc. is EZ1.F.
Which industry does the Enzon Pharmaceuticals, Inc. company belong to?
The Enzon Pharmaceuticals, Inc. industry is Biotechnology.
How many shares does Enzon Pharmaceuticals, Inc. have in circulation?
The max supply of Enzon Pharmaceuticals, Inc. shares is 76.2M.
What is Enzon Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Enzon Pharmaceuticals, Inc. PE Ratio is now.
What was Enzon Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Enzon Pharmaceuticals, Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the Enzon Pharmaceuticals, Inc. company belong to?
The Enzon Pharmaceuticals, Inc. sector is Healthcare.